Key terms

About NVAX

Novavax, Inc. Is a biotechnology company, which engages in the discovery, development, and commercialization of recombinant vaccines. The company was founded in 1987 and is headquartered in Gaithersburg, MD.

Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
     
52-week range
     
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date

Key terms

Smart score

Latest NVAX news

Nov 22 11:30am ET Trump Trade: Trump Media considers developing crypto payment service by TipRanks Nov 22 9:50am ET Trump expected to pick Martin Makary to head FDA, Reuters reports by TipRanks Nov 20 6:34am ET Novavax to Present at Jefferies London Conference by TipRanks Nov 18 8:15am ET Strategic Transformation and Growth Prospects: Mayank Mamtani’s Buy Rating on Novavax by TipRanks Nov 15 11:07am ET Moderna (MRNA) and Other Vaccine Stocks Fall on News of RFK Jr. Health Nomination by TipRanks Nov 14 4:35pm ET Vaccine makers fall after Trump nominates RFK to head HHS by TipRanks Nov 14 4:26pm ET Trump names Robert Kennedy as Secretary of Health and Human Services by TipRanks Nov 13 7:26am ET Novavax price target lowered to $9 from $14 at TD Cowen by TipRanks Nov 13 7:07am ET Novavax price target lowered to $12 from $14 at BofA by TipRanks Nov 13 6:16am ET Novavax’s Market Share and Pipeline Uncertainties Lead to Sell Rating by TipRanks Nov 13 5:06am ET Novavax: Balancing Potential and Risk Amid Strategic Shifts and Uncertain Market Outlook by TipRanks Nov 13 12:54am ET NVAX Earnings: Novavax Stock Down on Weak 2024 Revenue Outlook by TipRanks Nov 12 11:15pm ET Novavax Advances Vaccine Strategy Amid Financial Shifts by TipRanks Nov 12 3:25pm ET Novavax: Navigating Fiscal Challenges and Strategic Shifts Amid COVID Vaccine Market Uncertainty by TipRanks Nov 12 12:05pm ET Elliott confirms big Honeywell stake, Home Deport reports Q3 beat: Morning Buzz by TipRanks Nov 12 11:48am ET Novavax Resumes Phase 3 Vaccine Trials After FDA Hold by TipRanks Nov 12 8:12am ET Novavax reports Q3 EPS (76c), consensus (83c) by TipRanks Nov 12 8:11am ET Novavax cuts FY24 revenue view to $650M-$700M from $700M-$800M by TipRanks Nov 12 7:05am ET Options Volatility and Implied Earnings Moves Today, November 12, 2024 by TipRanks Nov 12 6:28am ET Novavax Gains Competitive Edge with FDA Clearance and Strategic Collaborations, Earning Buy Rating by TipRanks Nov 11 9:40am ET Unusually active option classes on open November 11th by TipRanks Nov 11 8:35am ET Novavax: FDA removes clinical hold on Covid-19/flu combo trial by TipRanks Nov 11 7:00am ET Options Volatility and Implied Earnings Moves This Week, November 11 – November 15, 2024 by TipRanks Nov 05 5:30pm ET Novavax Settles Vaccine Supply Agreement Dispute by TipRanks Oct 17 6:37am ET Novavax’s Regulatory Setback and Mid-Term Underperformance: An Analyst’s Perspective by TipRanks Oct 16 2:36pm ET Novavax (NASDAQ:NVAX) Stock Drops 18% as Clinical Trial Halted by TipRanks Oct 16 1:45pm ET Cautious Optimism for Novavax Amid Clinical Hold Challenges by TipRanks Oct 16 1:35pm ET Novavax price target lowered to $25 from $31 at Jefferies by TipRanks Oct 14 11:05am ET Novavax call volume above normal and directionally bullish by TipRanks Oct 10 8:15am ET Novavax price target raised to $26 from $23 at B. Riley by TipRanks Oct 10 7:36am ET Buy Rating Affirmed for Novavax Amid Strategic Alliances and Promising Vaccine Trials by TipRanks
Nov 18 9:00am ET Investors Heavily Search Novavax, Inc. (NVAX): Here is What You Need to Know by Zacks Nov 15 7:52am ET Vaccine Stocks Fall After Trump Selects RFK Jr. to Lead HHS by Zacks Nov 14 2:16pm ET Biotech Stock Roundup: NVAX Q3 Results, SNDX Down on AML Data, RNA Surges on Study Data by Zacks Nov 13 8:13am ET Novavax Q3 Earnings & Sales Beat, Stock Falls 6% on '24 View Cut by Zacks Nov 12 9:20am ET Novavax (NVAX) Reports Q3 Loss, Tops Revenue Estimates by Zacks Nov 11 10:46am ET Will These 5 Biotech Stocks Surpass Q3 Earnings Forecasts? by Zacks Nov 11 8:40am ET Novavax to Report Q3 Earnings: Here's What to Expect by Zacks Nov 05 10:00am ET Novavax (NVAX) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release by Zacks Nov 01 9:00am ET Here is What to Know Beyond Why Novavax, Inc. (NVAX) is a Trending Stock by Zacks Oct 29 5:45pm ET Novavax (NVAX) Stock Dips While Market Gains: Key Facts by Zacks Oct 23 5:45pm ET Novavax (NVAX) Registers a Bigger Fall Than the Market: Important Facts to Note by Zacks Oct 21 9:00am ET Is Trending Stock Novavax, Inc. (NVAX) a Buy Now? by Zacks Oct 16 12:45pm ET Novavax, Inc. Investigation Ongoing: Contact Levi & Korsinsky About Potential Securities Fraud Allegations - NVAX by Accesswire

NVAX Financials

1-year income & revenue

Key terms

NVAX Forecasts

analyst rating

  • buy
  • hold
  • sell

We're sorry, but this
information is
temporarily unavailable.

1-year stock price forecast

NVAX Competitors

$ Market cap P/E ratio $ Price 1d change 52-week range

Key terms

Latest investing news

Target expects a sluggish holiday season.
David Paul Morris/Bloomberg/Getty Images
Target sounds the alarm bell on holiday shopping
Investors piled into safe havens like gold and US debt as tensions rose in Europe. Gold prices jumped on Tuesday and US Treasury rates dipped.
Angela Weiss/AFP/Getty Images
Stocks shrug off concerns about heightened US-Russia tensions
A lone shopper places items in her cart in the frozen food aisle of a Walmart store Thursday, Nov. 14, 2024, in Englewood, Colo.
David Zalubowski/AP
As Americans bargain shop, six-figure earners flock to Walmart
NEW YORK, NEW YORK - JULY 07: Bikes with Grubhub bags sit on the street on July 07, 2023 in New York City. Grubhub, DoorDash and Uber Eats sued the City of New York on July 6th in order to block its new minimum pay rules for food delivery workers. (Photo by Leonardo Munoz/VIEWpress)
Leonardo Munoz/VIEWpress/Getty Images
Grubhub just sold for $650 million. Four years ago it was worth $7.3 billion